Scientists generated patient-derived CALRins5- or CALRdel52-positive iPSCs to establish a myeloproliferative neoplasms disease model for molecular and mechanistic studies.
[Stem Cell Reports]
7992332
DDDDDDDD
items
1
apa
0
default
asc
1
168056
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
